116 related articles for article (PubMed ID: 7556747)
1. Automated achromatic contrast and chromatic discrimination sensitivity testing in dysthyroid optic neuropathy.
Tanner V; Tregear SJ; Ripley LG; Vickers SF
Eye (Lond); 1995; 9 ( Pt 3)():352-7. PubMed ID: 7556747
[TBL] [Abstract][Full Text] [Related]
2. Correlation of chromatic, spatial, and temporal sensitivity in optic nerve disease.
Grigsby SS; Vingrys AJ; Benes SC; King-Smith PE
Invest Ophthalmol Vis Sci; 1991 Dec; 32(13):3252-62. PubMed ID: 1748555
[TBL] [Abstract][Full Text] [Related]
3. Selective endoscopic decompression of the orbital apex for dysthyroid optic neuropathy.
Chu EA; Miller NR; Lane AP
Laryngoscope; 2009 Jun; 119(6):1236-40. PubMed ID: 19418538
[TBL] [Abstract][Full Text] [Related]
4. Long-term visual outcome following orbital decompression for dysthyroid eye disease.
Hutchison BM; Kyle PM
Eye (Lond); 1995; 9 ( Pt 5)():578-81. PubMed ID: 8543076
[TBL] [Abstract][Full Text] [Related]
5. Spatial and temporal chromatic contrast: Effects on chromatic discrimination for stimuli varying in L- and M-cone excitation.
Zele AJ; Smith VC; Pokorny J
Vis Neurosci; 2006; 23(3-4):495-501. PubMed ID: 16961986
[TBL] [Abstract][Full Text] [Related]
6. Orientation selectivity in luminance and color vision assessed using 2-d band-pass filtered spatial noise.
Beaudot WH; Mullen KT
Vision Res; 2005 Mar; 45(6):687-96. PubMed ID: 15639495
[TBL] [Abstract][Full Text] [Related]
7. Amplitude of the transient visual evoked potential (tVEP) as a function of achromatic and chromatic contrast: contribution of different visual pathways.
Souza GS; Gomes BD; Lacerda EM; Saito CA; da Silva Filho M; Silveira LC
Vis Neurosci; 2008; 25(3):317-25. PubMed ID: 18321403
[TBL] [Abstract][Full Text] [Related]
8. Normal and dichromatic color discrimination measured with transient visual evoked potential.
Gomes BD; Souza GS; Rodrigues AR; Saito CA; Silveira LC; da Silva Filho M
Vis Neurosci; 2006; 23(3-4):617-27. PubMed ID: 16962005
[TBL] [Abstract][Full Text] [Related]
9. [A new method of assessing contrast sensitivity in patients with eye diseases].
Shamshinova AM; Belozerov AE; Shapiro VM; Eskina EN; Aref'eva IuA; Barsegian GL
Vestn Oftalmol; 1997; 113(1):22-5. PubMed ID: 9133038
[TBL] [Abstract][Full Text] [Related]
10. Orbital decompression as an alternative management strategy for patients with benign tumors located at the orbital apex.
Kloek CE; Bilyk JR; Pribitkin EA; Rubin PA
Ophthalmology; 2006 Jul; 113(7):1214-9. PubMed ID: 16815404
[TBL] [Abstract][Full Text] [Related]
11. Brightness sensitivity and color perception as predictors of relative afferent pupillary defect.
Danesh-Meyer HV; Papchenko TL; Savino PJ; Gamble GD
Invest Ophthalmol Vis Sci; 2007 Aug; 48(8):3616-21. PubMed ID: 17652731
[TBL] [Abstract][Full Text] [Related]
12. Symptomatic compression of the optic nerve by the carotid artery: clinical profile of 18 patients with 24 affected eyes identified by magnetic resonance imaging.
Jacobson DM
Ophthalmology; 1999 Oct; 106(10):1994-2004. PubMed ID: 10519598
[TBL] [Abstract][Full Text] [Related]
13. Chromatic, spatial, and temporal losses of sensitivity in multiple sclerosis.
Dain SJ; Rammohan KW; Benes SC; King-Smith PE
Invest Ophthalmol Vis Sci; 1990 Mar; 31(3):548-58. PubMed ID: 2318594
[TBL] [Abstract][Full Text] [Related]
14. Transcaruncular orbital decompression: an alternate procedure for Graves ophthalmopathy with compressive optic neuropathy.
Liao SL; Chang TC; Lin LL
Am J Ophthalmol; 2006 May; 141(5):810-818. PubMed ID: 16527228
[TBL] [Abstract][Full Text] [Related]
15. Chromatic and luminance losses with multiple sclerosis and optic neuritis measured using dynamic random luminance contrast noise.
Flanagan P; Zele AJ
Ophthalmic Physiol Opt; 2004 May; 24(3):225-33. PubMed ID: 15130171
[TBL] [Abstract][Full Text] [Related]
16. The effect of glaucoma on central visual function.
Stamper RL
Trans Am Ophthalmol Soc; 1984; 82():792-826. PubMed ID: 6398938
[TBL] [Abstract][Full Text] [Related]
17. Flash and pattern visual evoked potentials in the diagnosis and monitoring of dysthyroid optic neuropathy.
Tsaloumas MD; Good PA; Burdon MA; Misson GP
Eye (Lond); 1994; 8 ( Pt 6)():638-45. PubMed ID: 7867819
[TBL] [Abstract][Full Text] [Related]
18. Blue-light filtering intraocular lens in patients with diabetes: contrast sensitivity and chromatic discrimination.
Rodríguez-Galietero A; Montés-Micó R; Muñoz G; Albarrán-Diego C
J Cataract Refract Surg; 2005 Nov; 31(11):2088-92. PubMed ID: 16412920
[TBL] [Abstract][Full Text] [Related]
19. Chromatic discrimination losses in multiple sclerosis patients with and without optic neuritis using the Cambridge Colour Test.
Moura AL; Teixeira RA; Oiwa NN; Costa MF; Feitosa-Santana C; Callegaro D; Hamer RD; Ventura DF
Vis Neurosci; 2008; 25(3):463-8. PubMed ID: 18598419
[TBL] [Abstract][Full Text] [Related]
20. Spectral sensitivity in patients with dysthyroid eye disease.
Sharanjeet-Kaur ; Dickinson CM; O'Donoghue E; Murray IJ
Ophthalmic Physiol Opt; 1997 May; 17(3):232-8. PubMed ID: 9196665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
